Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Cell Tissue Res ; 359(3): 841-51, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25487403

ABSTRACT

Hodgkin's lymphoma (HL) is among the most frequent nodal lymphomas in the Western world and is classified into two disease entities: nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL) and classical Hodgkin's lymphoma (cHL, 95% of all HL). HL lesions are characterised by a minority of clonal neoplastic cells, namely Hodgkin and Reed-Sternberg (HRS) cells and their variants in cHL and lymphocyte-predominant (LP) cells in NLPHL, both occurring within a microenvironment of, for example, reactive T and B cells, macrophages and granulocytes that are assumed to support the proliferation and maintenance of neoplastic cells through cytokines, chemokines and growth factors. Insulin-like growth factor I (IGF-I) is an important growth factor involved in proliferation, differentiation, apoptosis and cell survival of numerous (including immune) tissues and probably has a role in tumour pathogenesis and maintenance. Although HL is characterised by disturbed cell differentiation and apoptosis mechanisms, with the involvement of the IGF-I receptor (IGF-1R), the distinct location of IGF-I in HL has not yet been defined. We localise IGF-I by double-immunofluorescence in frequent neoplastic cells of all cHL and NLPHL cases investigated. Additionally, IGF-I immunoreactivity is detected in high endothelial venules and various immune cells within the surrounding tissue of cHL including neutrophils and macrophages. IGF-1R immunoreactivity of variable intensity is found in HRS cells and high endothelial venules within the microenvironment in cHL. We assume that autocrine and paracrine IGF-I plays an anti-apoptotic role in tumour pathogenesis and in shaping the tumour microenvironment.


Subject(s)
Hodgkin Disease/metabolism , Hodgkin Disease/pathology , Insulin-Like Growth Factor I/metabolism , Lymphocytes/metabolism , Tumor Microenvironment , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Lewis X Antigen/metabolism , Male , Middle Aged , Sclerosis , Young Adult
2.
Urol Int ; 90(1): 17-23, 2013.
Article in English | MEDLINE | ID: mdl-23095725

ABSTRACT

INTRODUCTION: Active surveillance needs a precise grading diagnosis of a low-grade carcinoma of the prostate (Gleason score (GS) 6) within a small organ-confined tumor. However, how accurate is the gold standard of GS 6 in predicting a small pT2 carcinoma? To answer this question, we have analyzed grading systems in this study. METHODS: Prostatic carcinomas in biopsy and corresponding radical prostatectomy (RP) specimens of 960 patients were graded by the Gleason system in which glandular fusions and nucleolar stage (prominence and location) were considered. RESULTS: Using the modified Gleason grading, a high upgrading rate from the biopsy to RP specimens (GS 6-7) and in even 30% a non-organ-confined growth pattern (pT3) of GS 6 carcinoma in RP was found. When considering glandular fusion and the incorporation of the state of nucleoli within the Gleason grading, the agreement of score 6 between biopsy and RP specimens as well as the prediction of a pT2a tumor increased from about 80 to 90%. CONCLUSION: The combination of Gleason grading and grading of the nuclear and nucleolar features may help to identify patients eligible for active surveillance.


Subject(s)
Carcinoma/pathology , Prostatic Neoplasms/pathology , Watchful Waiting , Biopsy, Large-Core Needle , Carcinoma/surgery , Cell Nucleus/pathology , Chi-Square Distribution , Disease Progression , Humans , Male , Neoplasm Grading , Patient Selection , Predictive Value of Tests , Prognosis , Prostatectomy , Prostatic Neoplasms/surgery , Time Factors
3.
Immunology ; 128(3): 342-50, 2009 Nov.
Article in English | MEDLINE | ID: mdl-20067534

ABSTRACT

Insulin-like growth factor I (IGF-I) is a potent hormone that stimulates growth and differentiation and inhibits apoptosis in numerous tissues. Preliminary evidence suggests that IGF-I exerts differentiating, mitogenic and restoring activities in the immune system but the sites of synthesis of local IGF-I are unknown. Identification of these sites would allow the functional role of local IGF-I to be clarified. The presence of IGF-I in non-immune cells suggests that it acts as a trophic factor, while its occurrence in subtypes of lymphocytes or antigen-presenting cells indicates paracrine/autocrine direct regulatory involvement of IGF-I in the human immune response. The present study investigated the location of IGF-I messenger RNA and protein on archival human lymph node samples by in situ hybridization, immunohistochemistry and double immunofluorescence staining using an IGF-I probe and antisera specific for human IGF-I and CD3 (T lymphocytes), CD20 (B lymphocytes), CD68 (macrophages), CD21 (follicular dendritic cells), S100 (interdigitating dendritic cells) and podoplanin (fibroblastic reticular cells). Numerous cells within the B- and T-cell compartments expressed the IGF-I gene, and the majority of these cells were identified as macrophages. Solitary follicular dendritic cells exhibited IGF-I. A few T lymphocytes, and no B lymphocytes, contained IGF-I immunoreactive material. Furthermore, IGF-I immunoreactive cells outside the follicles that did not react with CD3, CD20, S100 or podoplanin markers were identified as high-endothelial venule (HEV) cells. From this we conclude that the main task of IGF-I in human non-tumoral lymph node may be autocrine and paracrine regulation of the differentiation, stimulation and survival of lymphocytes, antigen-presenting cells and macrophages and the differentiation and maintenance of HEV cells.


Subject(s)
Antigen-Presenting Cells/metabolism , Endothelium, Vascular/metabolism , Insulin-Like Growth Factor I/metabolism , Lymphocytes/metabolism , RNA, Messenger/analysis , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/pathology , Antigens, CD/biosynthesis , Calgranulin A/biosynthesis , Endothelium, Vascular/immunology , Endothelium, Vascular/pathology , Fluorescent Antibody Technique , Gene Expression Profiling , Humans , Immunohistochemistry , In Situ Hybridization , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/immunology , Lymph Nodes/pathology , Lymphocytes/immunology , Lymphocytes/pathology , Membrane Glycoproteins/biosynthesis
4.
Clin Cancer Res ; 11(16): 5730-9, 2005 Aug 15.
Article in English | MEDLINE | ID: mdl-16115910

ABSTRACT

PURPOSE: To address the progression, metastasis, and clinical heterogeneity of renal cell cancer (RCC). EXPERIMENTAL DESIGN: Transcriptional profiling with oligonucleotide microarrays (22,283 genes) was done on 49 RCC tumors, 20 non-RCC renal tumors, and 23 normal kidney samples. Samples were clustered based on gene expression profiles and specific gene sets for each renal tumor type were identified. Gene expression was correlated to disease progression and a metastasis gene signature was derived. RESULTS: Gene signatures were identified for each tumor type with 100% accuracy. Differentially expressed genes during early tumor formation and tumor progression to metastatic RCC were found. Subsets of these genes code for secreted proteins and membrane receptors and are both potential therapeutic or diagnostic targets. A gene pattern ("metastatic signature") derived from primary tumor was very accurate in classifying tumors with and without metastases at the time of surgery. A previously described "global" metastatic signature derived by another group from various non-RCC tumors was validated in RCC. CONCLUSION: Unlike previous studies, we describe highly accurate and externally validated gene signatures for RCC subtypes and other renal tumors. Interestingly, the gene expression of primary tumors provides us information about the metastatic status in the respective patients and has the potential, if prospectively validated, to enrich the armamentarium of diagnostic tests in RCC. We validated in RCC, for the first time, a previously described metastatic signature and further showed the feasibility of applying a gene signature across different microarray platforms. Transcriptional profiling allows a better appreciation of the molecular and clinical heterogeneity in RCC.


Subject(s)
Carcinoma, Renal Cell/genetics , Gene Expression Profiling , Kidney Neoplasms/genetics , Adult , Aged , Carcinoma, Renal Cell/pathology , Cluster Analysis , Disease Progression , Down-Regulation/genetics , Female , Gene Expression Regulation, Neoplastic/genetics , Humans , Kidney Neoplasms/pathology , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Staging , Oligonucleotide Array Sequence Analysis , Up-Regulation/genetics
5.
Ann Thorac Surg ; 79(2): e15-6, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15680798

ABSTRACT

Granular cell tumors are uncommon benign neoplasms. Their location is mostly in the head and neck region; appearance in other parts of the body is rare, but it has been reported. We present the case of a 14-year-old girl with a granular cell tumor of the trachea. The tumor was incidentally found at bronchoscopy performed to exclude suspected foreign body aspiration. It was located in the ventral part of the main carina. Biopsies revealed the histologic pattern of a benign granular cell tumor. The girl underwent resection of the main carina followed by reconstruction of a neo-carina with both main bronchi. She has not had any recurrence of the tumor during 3 years of follow-up.


Subject(s)
Granular Cell Tumor/diagnosis , Granular Cell Tumor/surgery , Tracheal Neoplasms/diagnosis , Tracheal Neoplasms/surgery , Adolescent , Biopsy , Bronchoscopy , Cough/etiology , Diagnosis, Differential , Female , Foreign-Body Reaction/diagnosis , Granular Cell Tumor/pathology , Humans , Pneumonia, Aspiration/diagnosis , Tracheal Neoplasms/pathology
6.
Breast ; 13(1): 80-1, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14759723

ABSTRACT

The proto-oncogene pituitary tumor-transforming gene (PTTG) is described as abundantly overexpressed in a variety of neoplasms and cancer cell lines. We analyzed PTTG mRNA expression in 72 tumor samples derived from primary tumors of patients suffering from breast cancer and in unaffected breast epithelium, checking for correlations between expression levels and standard clinico-pathological parameters over a 5-year observation period. We found a direct correlation between PTTG mRNA overexpression and lymph node infiltration. Furthermore, overexpression of this gene in tumors correlated with a higher degree of tumor recurrence within the subsequent observation period. Taken together, these results demonstrate that determination of PTTG expression in primary tumors of the breast is a powerful tool for the assessment of potential tumor aggressiveness.


Subject(s)
Biomarkers, Tumor/biosynthesis , Breast Neoplasms/metabolism , Neoplasm Proteins/biosynthesis , Neoplasm Recurrence, Local/metabolism , Biomarkers, Tumor/genetics , Breast Neoplasms/pathology , Case-Control Studies , Female , Gene Expression Regulation, Neoplastic , Humans , Lymphatic Metastasis , Neoplasm Proteins/genetics , Neoplasm Recurrence, Local/pathology , Predictive Value of Tests , Proto-Oncogene Mas , RNA, Messenger/analysis , Securin
7.
Virchows Arch ; 442(3): 284-93, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12647220

ABSTRACT

The World Health Organization (WHO) classification of Hodgkin lymphoma (HL) distinguishes two types: Classical Hodgkin lymphoma (CHL) and nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). Both groups have in common that they mostly derive from B cells with rare classical cases originating from T cells. They differ in their histomorphology, immunophenotype, and clinical behavior. One of the subtypes of CHL, designated as lymphocyte-rich classical Hodgkin lymphoma (LRCHL), shares some morphological features with NLPHL. The transcription factors BSAP, BOB.1, Oct2 and MUM1 are sequentially expressed in normal B-cell development. In order to investigate the relationship between the CHL subgroups and NLPHL, we examined the protein expression of these transcription factors using immunohistochemistry in 15 reactive processes and 4 different subtypes of 58 HL cases. Our findings underline the B-cell origin of HL, without evidence, that reactive processes like progressively transformed germinal centers (PTGCs) are precursor lesions of HL. Furthermore, they demonstrate that LRCHL is distinct from NLPHL and that it is closely related to the mixed cellularity CHL (MCHL) in respect of BSAP, BOB.1, and Oct2 expression. It therefore occupies an intermediate position between MCHL and NLPHL. Based on MUM1 staining, LRCHL exhibits a more mature phenotype than NLPHL.


Subject(s)
DNA-Binding Proteins , Hodgkin Disease/metabolism , Transcription Factors/analysis , B-Lymphocytes/chemistry , DNA-Binding Proteins/analysis , Hodgkin Disease/pathology , Humans , Immunohistochemistry , Interferon Regulatory Factors , Lymph Nodes/chemistry , Lymph Nodes/pathology , Octamer Transcription Factor-2 , PAX5 Transcription Factor , Trans-Activators/analysis
8.
9.
Dermatology ; 205(3): 239-44, 2002.
Article in English | MEDLINE | ID: mdl-12399670

ABSTRACT

BACKGROUND: The etiopathology of chronic eczematous lesions of the palms and/or soles remains elusive in a considerable proportion of patients. Accumulating evidence suggests that a rare variant of mycosis fungoides (MF)-type cutaneous T cell lymphoma (CTCL) restricted to the palms and/or soles may mimic common palmoplantar dermatoses. OBJECTIVE: In the present study, we analyzed the clinical and histological characteristics of 3 adult patients with preexisting nonclassified chronic palmoplantar eczema poorly responding to standard therapies. Palmar and/or plantar MF was eventually diagnosed. METHODS: The course of the disease, response to previous therapies and dermatological features are described, results of histochemical and immunohistochemical analyses are reported, including T cell receptor gamma gene rearrangement where obtainable. RESULTS: Onset of cutaneous lesions with broad clinical variation was experienced 2-10 years prior to diagnosis; conventional therapies led to short-time or partial remission only; except for 1 patient, the epidermotropic infiltrate was predominantly composed of CD4-positive cells; topical photochemotherapy seems to result in more durable responses. CONCLUSION: As therapeutic strategies for this disease variant differ from symptomatic standard treatment regimens, awareness of MF-type CTCL as a relevant differential diagnosis of palmoplantar eczema should be expanded to prevent delay in diagnosis and adequate therapy.


Subject(s)
Mycosis Fungoides/diagnosis , Skin Neoplasms/diagnosis , Aged , Diagnosis, Differential , Diagnostic Errors , Female , Foot/pathology , Hand/pathology , Humans , Male , Middle Aged , Mycosis Fungoides/drug therapy , PUVA Therapy , Skin Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...